D-202-2013 Class II Terminated
FDA drug recall D-202-2013 was initiated by Zydus Pharmaceuticals USA Inc on Mar 5, 2013 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle. The recall status is terminated (terminated May 4, 2015). Affected quantity: 13,320 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 3, 2013
- Initiation Date
- Mar 5, 2013
- Termination Date
- May 4, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,320 bottles
Product description
Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-021-01.
Reason for recall
Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.
Distribution pattern
Nationwide.
Code information
Lot #: MM8490, Exp 09/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-202-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026